Hovione, a pharmaceutical company, will be undertaking a major expansion of its East Windsor facility.
The company, which has its headquarters in Portugal, will add an additional 30,600 square feet to its existing 24,000-square-foot facility located at 40 Lake Drive.
The expansion will provide for the addition of a new commercial spray dryer unit designed to handle intermediate drug products. The expansion will also more than double the drug substance capacity at the site and add approximately 60 new jobs to the current workforce.
Mayor Janice Mironov said Hovione is a high-tech, high-growth pharmaceutical-related company that keeps with the township’s “Einstein’s Alley” designation and vision.
“The Hovione expansion plan is great news for the township and another sign of our business vibrancy,” Mayor Mironov said. “This expansion marks a significant investment by Hovione in East Windsor, bringing new tax dollars, ensuring existing jobs and adding a large number of new jobs to our community. We are gratified that Hovione has found East Windsor to be such a beneficial home for their business, and that their business is on such a positive growth pathway here.”
The official groundbreaking should occur in the first quarter of 2016 and the doubling of capacity is expected to be fully operational in early 2017.
“Expanding our manufacturing presence in the USA highlights our commitment to our customers that want to manufacture their products in the US and to support the development needs of our ever-expanding local customer base,” Hovione New Jersey General Manager Marco Gil said. “The additional capacity will give us more flexibility and make us more agile to deal with our customer’s fast- paced projects.”
According to Hovione, this investment is part of the company’s strategy to increase its global development and commercial capacity to meet the increasing demands of Hovione’s customers.
“This investment pays a tribute to the excellent work that Hovione’s New Jersey team has done to create a sustainable business for the company in the US. We trust the team in New Jersey to be an integral part of Hovione’s overall expansion,” Dave Hoffman, president of Hovione US Operations, said. “The state and especially the local government have been extremely supportive of us in the past and in our growth plans for the future and we are excited to partner with them to create new jobs in the local community.”
Hovione is an international company with over 50 years of experience in the development and compliant manufacture of active pharmaceutical ingredients and drug product intermediates, and has four US Food and Drug Administration-inspected sites in the US, China, Ireland, and Portugal.
